Speech-Language Pathologists in Painted Post, NY Accepting Medicare

12 Speech-Language Pathologists found. Showing 1 - 12

Jessica Frisbie, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9579 Vocational Dr, Painted Post, NY 14870 Phone: 607-739-3581

Mrs. Suzanne D. Smith, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9579 Vocational Dr, Painted Post, NY 14870 Phone: 607-962-3175

Cynthia Driscoll, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9579 Vocational Dr, Painted Post, NY 14870 Phone: 607-739-3581

Mrs. Susanna Mason, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107 Fieldview Dr, Painted Post, NY 14870 Phone: 607-329-0026

Carrie Ann Welty, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 165 Charles St, Painted Post, NY 14870 Phone: 607-936-3704

Mrs. Jennifer Ann Glosenger, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3414 Stanton St, Calvin U Smith Elementary School, Painted Post, NY 14870 Phone: 607-936-4156    Fax: 607-654-2859

Mrs. Tiffany Nicole Zygmunt, M.S CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 122 Fairview Ave, Painted Post, NY 14870 Phone: 716-863-9272

Katherine M Deragon, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Fieldview Dr, Painted Post, NY 14870 Phone: 607-377-6425

Ms. Jenelle Carr Glover, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16 Beartown Rd, Painted Post, NY 14870 Phone: 607-936-6514

Miss Gretchen Laura Smith, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 165 Charles St, Painted Post, NY 14870 Phone: 607-654-2729

Mrs. Chelsea Catherine Chimblo Smith, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9579 Vocational Dr, Painted Post, NY 14870 Phone: 607-739-3581

Bridget Collins Flynn Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 165 Charles St, Painted Post, NY 14870 Phone: 607-936-3704

News Archive

Roundup: State employee benefit battles heat up; Wis. Gov. to remake Medicaid program; Mass. cost controls

The Legislature is close to wrapping up its work on the $25 billion state budget bill after the Senate made minor changes to the plan late Sunday before approving it by a lopsided margin. ... the spending plan for the budget year that starts July 1 would eliminate more than 2,000 state jobs and includes cuts in most state departments and agencies.

Over 40% of older adults experienced less financial strain during the recession period

The "Great Recession" may have put a dent in many older adults' pocketbooks, but a new study, which will be presented at the 109th Annual Meeting of the American Sociological Association, finds that more than 40 percent reported a decrease in "financial strain" between 2006 and 2010.

Study finds sevenfold rise in prescription opioid use among fatally injured drivers

The percentage of fatally injured drivers who tested positive for prescription opioids rose sevenfold from 1 percent in 1995 to over 7 percent in 2015, according to a new study at Columbia University's Mailman School of Public Health. The findings appear online in the American Journal of Public Health.

Isis Pharmaceuticals starts ISIS-SMNRx Phase 2 study in infants with SMA

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

Genta Incorporated announced that two new studies have shown that Genasense (oblimersen sodium) Injection, the Company's lead anticancer drug, showed synergistic activity with both bortezomib (Velcade; Millennium Pharmaceuticals, Inc.) and rituximab (Rituxan; Genentech, Idec) in experimental models of B-cell non-Hodgkin's lymphoma (NHL).

Read more Medical News

› Verified 1 days ago